CHOOM™ SIGNS DEFINITIVE AGREEMENT TO ACQUIRE ISLAND GREEN CURE

Choom™ (CSE: CHOO; OTCQB: CHOOF), announced today that it has entered into a definitive agreement to acquire Island Green Cure Ltd an advanced-stage cannabis production license applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).

Canadian Cannabis Sector Thriving Despite Slow Legalization Process

Despite legislative delays, the legalization of recreational cannabis will take place in Canada, likely by the end of summer at the latest. Companies are coming to grips with the licensing process and are ready to reach this new market. One of the leaders in the new industry is Choom Holdings, Inc. (CSE: CHOO) (OTC: CHOOF), which has gained licensing experience and developed a slick brand designed to appeal to the recreational market

Maricann Group Inc. Receives Export Permit From Health Canada

Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF), is pleased to announce that on Friday April13th, 2018, its wholly owned subsidiary, Maricann Inc. received an export permit from Health Canada for a shipment of dried cannabis flower to Germany.

Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), CanniMed Therapeutics Inc. (TSX: CMED) and CTT Pharmaceutical Holdings, Inc., (OTC:CTTH) announced today that further to the CanniMed/CTT news release of February 17, 2017, the companies have entered into a three-way agreement that provides Aurora, through its ownership of CanniMed, with joint exclusivity on the distribution in Canada of CTT's novel, patented drug delivery technologies.